CymaBay Therapeutics Inc. (CBAY)

NASDAQ: CBAY · Delayed Price · USD
1.97
0.05 (2.60%)
At close: May 26, 2022 4:00 PM
2.06
0.09 (4.57%)
After-hours:May 26, 2022 5:17 PM EDT

Income Statement (Annual)

Millions USD. Fiscal year is Jan - Dec.
Year20212020201920182017201620152014201320122011
Revenue
00001000003.05
Upgrade
Gross Profit
00001000003.05
Upgrade
Selling, General & Admin
23.0416.7219.2414.3812.399.658.878.194.874.21
Upgrade
Research & Development
64.5435.8883.8458.1218.9415.9417.0315.824.539.28
Upgrade
Other Operating Expenses
005.080000000
Upgrade
Operating Expenses
87.5852.6108.1572.5131.3325.5925.924.019.413.49
Upgrade
Operating Income
-87.58-52.6-108.15-72.51-21.33-25.59-25.9-24.01-9.4-10.44
Upgrade
Interest Expense / Income
2.58000.341.081.340.910.760.820.84
Upgrade
Other Expense / Income
-0.17-1.62-5.34-0.295.15-0.25-11.287.15-254.2112.62
Upgrade
Pretax Income
-90-50.99-102.81-72.55-27.56-26.67-15.53-31.92243.99-23.9
Upgrade
Net Income
-90-50.99-102.81-72.55-27.56-26.67-15.53-31.92243.99-23.9
Upgrade
Net Income Common
-90-50.99-102.81-72.55-27.56-26.67-15.53-31.92243.99-23.9
Upgrade
Shares Outstanding (Basic)
716967583523191220
Upgrade
Shares Outstanding (Diluted)
716967583523191230
Upgrade
Shares Change
3.14%2.77%15.90%65.71%48.86%23.95%57.00%323.42%49063.94%-
Upgrade
EPS (Basic)
-1.27-0.74-1.53-1.25-0.79-1.14-0.82-2.65103.52-4.00
Upgrade
EPS (Diluted)
-1.27-0.74-1.53-1.26-0.79-1.14-0.83-2.65-3.54-4.00
Upgrade
Free Cash Flow Per Share
-0.98-0.65-1.47-0.96-0.56-1.00-1.23-1.76-3.31-1.00
Upgrade
Gross Margin
----100.00%----100.00%
Upgrade
Operating Margin
-----213.25%-----342.23%
Upgrade
Profit Margin
-----275.57%-----783.57%
Upgrade
Free Cash Flow Margin
-----196.59%-----370.26%
Upgrade
EBITDA
-86.73-50.35-102.24-72.11-26.44-25.31-14.59-31.14244.87-22.94
Upgrade
EBITDA Margin
-----264.42%-----752.10%
Upgrade
EBIT
-87.42-50.99-102.81-72.21-26.48-25.33-14.62-31.16244.82-23.06
Upgrade
EBIT Margin
-----264.77%-----756.00%
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).